Hvilken er prisen på Pure Biologics Spólka Akcyjna (PUR)

Prisen på Pure Biologics Spólka Akcyjna (PUR) er $0.8248572

Hva er markedsverdien på Pure Biologics Spólka Akcyjna (PUR)

Markedsverdien på Pure Biologics Spólka Akcyjna (PUR) er $6.60M

Pure Biologics Spólka Akcyjna (PUR) Inntjening

Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise, concentrating its efforts on the discovery and development of novel biological pharmaceuticals and targeted, non-systemic treatments. The company's key therapeutic interests span immuno-oncology, various autoimmune conditions, and rare diseases. Its capabilities encompass the entire process for antibodies and aptamers, from their initial creation and purification to detailed analysis and characterization. Additionally, Pure Biologics is skilled in the design, development, and rigorous validation of diagnostic and research assays, while also advancing technology platforms for the precise selection of active therapeutic molecules. A significant offering is PureApta, a adaptable platform engineered for the in vitro selection of modified aptamers, suitable for both medical treatment and diagnostic applications. The firm is also actively pursuing the development of localized therapies aimed at assisting individuals afflicted by neurological autoimmune disorders, including conditions like neuromyelitis optica and myasthenia gravis. Founded in 2010, Pure Biologics Spólka Akcyjna is headquartered in Wroclaw, Poland.

År	Inntekter	Endre
Ikke nok data for de angitte datoene.

År

Inntekter

Endre

Ikke nok data for de angitte datoene.

Selskap	Inntekter	Forskjell i inntekter	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$3.01B	-	BE

Selskap

Inntekter

Forskjell i inntekter

Land